BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

Similar documents
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

ANTICONVULSANT THERAPY

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

2018 Step Therapy (ST) Criteria

2017 Step Therapy (ST) Criteria

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

Drugs That Require Step Therapy (ST) Step Therapy Medications

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Drugs That Require Step Therapy (ST) Step Therapy Medications

Step Therapy Requirements

Step Therapy Requirements

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

ADHD STIMULANTS-S(SHC)

Step Therapy Criteria

ANTICONVULSANT STEP THERAPY

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

Step Therapy Medications

Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy...

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Uniform Formulary Decisions 9 January 2014

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2019 Step Therapy (ST) Criteria

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

ALLERGIC CONJUNCTIVITIS AGENTS

ATYPICAL ANTIPSYCHOTICS

ALLERGIC RHINITIS-NASAL

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

STEP THERAPY CRITERIA

STEP THERAPY ALGORITHMS PUP Select Formulary

Step Therapy Criteria

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Health New England (HNE) is making some changes to your Plan, most of which become effective July 1, 2015.

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Drug Class Preferred Agents Non-Preferred Agents

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

2019 Simply Step Therapy Document

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Step Therapy Requirements. Effective: 05/01/2018

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2018 GRS Premier Step Therapy Document. September 2018 Y0114_18_33177_I_010

Step Therapy Criteria 2019

Step Therapy Requirements. Effective: 11/01/2018

2018 Step Therapy Criteria (List of Step Therapy Criteria)

The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

2015 Printable Drug List

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

2019 GRS Premier Step Therapy Document

ANGIOTENSIN RECEPTOR BLOCKERS

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA

ACYCLOVIR OINT (CCHP2017)

Pharmacy Updates Summary

2016 Step Therapy (ST) Criteria

Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Drug Class Prior Authorization Protocol

MOST Operations Manual page 1 MEDICATION INVENTORY

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

STEP THERAPY IN MEDICARE PART D

Quarterly Pharmacy Formulary Change Notice

Transcription:

BYSTOLIC BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): generic beta-blockers and/or combinations, Sorine. Step 2 Drug(s): Bystolic. 1

CNS STIMULANTS DAYTRANA 10 MG/9 HR DAILY PATCH DAYTRANA 15 MG/9 HR DAILY PATCH DAYTRANA 20 MG/9 HR DAILY PATCH DAYTRANA 30 MG/9 HR DAILY PATCH STRATTERA 10 MG CAPSULE STRATTERA 100 MG CAPSULE STRATTERA 18 MG CAPSULE STRATTERA 25 MG CAPSULE STRATTERA 40 MG CAPSULE STRATTERA 60 MG CAPSULE STRATTERA 80 MG CAPSULE authorization for a Step 2 drug may be given. Step 1 Drug(s): generic from either the amphetamines or ADHD class. Step 2 Drug(s): Daytrana, Strattera. 2

DIFICID DIFICID 200 MG TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): metronidazole, vancomycin. Step 2 Drug(s): Dificid 3

DPP-4 ALOGLIPTIN 12.5 MG TABLET ALOGLIPTIN 12.5 MG-METFORMIN 1,000 MG TABLET ALOGLIPTIN 12.5 MG-METFORMIN 500 MG TABLET ALOGLIPTIN 25 MG TABLET ALOGLIPTIN 6.25 MG TABLET KAZANO 12.5 MG-1,000 MG TABLET KAZANO 12.5 MG-500 MG TABLET KOMBIGLYZE XR 2.5 MG-1,000 MG TABLET,EXTENDED RELEASE KOMBIGLYZE XR 5 MG-1,000 MG TABLET,EXTENDED RELEASE KOMBIGLYZE XR 5 MG-500 MG TABLET,EXTENDED RELEASE NESINA 12.5 MG TABLET NESINA 25 MG TABLET NESINA 6.25 MG TABLET ONGLYZA 2.5 MG TABLET ONGLYZA 5 MG TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): Januvia, Janumet, Janumet XR, Tradjenta, Jentadueto, Jentadueto XR. Step 2 Drug(s): Onglyza, Kombiglyze, Nesina, Kazano, Alogliptin, and Alogliptin/metformin. 4

MIGRAINE THERAPY MIGERGOT 2 MG-100 MG RECTAL SUPPOSITORY RELPAX 20 MG TABLET RELPAX 40 MG TABLET ZOMIG 2.5 MG NASAL SPRAY ZOMIG 5 MG NASAL SPRAY authorization for a Step 2 drug may be given. Step 1 Drug(s): generic from serotonin agonists or migraine combination. Step 2 Drug(s): Migerot, Relpax, Zomig. 5

NASAL STEROIDS BECONASE AQ 42 MCG (0.042 %) NASAL SPRAY DYMISTA 137 MCG-50 MCG/SPRAY NASAL SPRAY OMNARIS 50 MCG NASAL SPRAY QNASL 80 MCG/ACTUATION NASAL AEROSOL SPRAY ZETONNA 37 MCG/ACTUATION NASAL HFA INHALER authorization for a Step 2 drug may be given. Step 1 Drug(s): generic nasal steroid. Step 2 Drug(s): Beconase AQ, Dymista, Omnaris, Qnasl, Zetonna. Beconase AQ will be approved first line for a diagnosis of nasal polyps. 6

OPHTHALMIC PROSTAGLANDINS BIMATOPROST 0.03 % EYE DROPS LUMIGAN 0.01 % EYE DROPS TRAVATAN Z 0.004 % EYE DROPS ZIOPTAN (PF) 0.0015 % EYE DROPS IN A DROPPERETTE authorization for a Step 2 drug may be given. Step 1 Drug(s): latanoprost. Step 2 Drug(s): Lumigan, Travatan Z, Zioptan, Bimatoprost. 7

OSTEOPOROSIS AGENT BINOSTO 70 MG EFFERVESCENT TABLET FORTEO 20 MCG/DOSE (600 MCG/2.4 ML) SUBCUTANEOUS PEN INJECTOR FOSAMAX PLUS D 70 MG-2,800 UNIT TABLET FOSAMAX PLUS D 70 MG-5,600 UNIT TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): alendronate, etidronate, ibandronate, pamidronate, risedronate, zoledronic acid, salmon calcitonin. Step 2 Drug(s): Binosto, Forteo, Fosamax + D. 8

ULORIC ULORIC 40 MG TABLET ULORIC 80 MG TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): allopurinol. Step 2 Drug(s): Uloric. 9

Index A ALOGLIPTIN 12.5 MG TABLET... 4 ALOGLIPTIN 12.5 MG-METFORMIN 1,000 MG TABLET... 4 ALOGLIPTIN 12.5 MG-METFORMIN 500 MG TABLET... 4 ALOGLIPTIN 25 MG TABLET... 4 ALOGLIPTIN 6.25 MG TABLET... 4 B BECONASE AQ 42 MCG (0.042 %) NASAL SPRAY... 6 BIMATOPROST 0.03 % EYE DROPS... 7 BINOSTO 70 MG EFFERVESCENT TABLET... 8 BYSTOLIC 10 MG TABLET... 1 BYSTOLIC 2.5 MG TABLET... 1 BYSTOLIC 20 MG TABLET... 1 BYSTOLIC 5 MG TABLET... 1 D DAYTRANA 10 MG/9 HR DAILY PATCH... 2 DAYTRANA 15 MG/9 HR DAILY PATCH... 2 DAYTRANA 20 MG/9 HR DAILY PATCH... 2 DAYTRANA 30 MG/9 HR DAILY PATCH... 2 DIFICID 200 MG TABLET... 3 DYMISTA 137 MCG-50 MCG/SPRAY NASAL SPRAY... 6 F FORTEO 20 MCG/DOSE (600 MCG/2.4 ML) SUBCUTANEOUS PEN INJECTOR... 8 FOSAMAX PLUS D 70 MG-2,800 UNIT TABLET... 8 FOSAMAX PLUS D 70 MG-5,600 UNIT TABLET... 8 K KAZANO 12.5 MG-1,000 MG TABLET.. 4 KAZANO 12.5 MG-500 MG TABLET... 4 KOMBIGLYZE XR 2.5 MG-1,000 MG TABLET,EXTENDED RELEASE... 4 KOMBIGLYZE XR 5 MG-1,000 MG TABLET,EXTENDED RELEASE... 4 KOMBIGLYZE XR 5 MG-500 MG TABLET,EXTENDED RELEASE... 4 L LUMIGAN 0.01 % EYE DROPS... 7 M MIGERGOT 2 MG-100 MG RECTAL SUPPOSITORY... 5 N NESINA 12.5 MG TABLET... 4 NESINA 25 MG TABLET... 4 NESINA 6.25 MG TABLET... 4 O OMNARIS 50 MCG NASAL SPRAY... 6 ONGLYZA 2.5 MG TABLET... 4 ONGLYZA 5 MG TABLET... 4 Q QNASL 80 MCG/ACTUATION NASAL AEROSOL SPRAY... 6 R RELPAX 20 MG TABLET... 5 RELPAX 40 MG TABLET... 5 S STRATTERA 10 MG CAPSULE... 2 STRATTERA 100 MG CAPSULE... 2 STRATTERA 18 MG CAPSULE... 2 STRATTERA 25 MG CAPSULE... 2 STRATTERA 40 MG CAPSULE... 2 STRATTERA 60 MG CAPSULE... 2 STRATTERA 80 MG CAPSULE... 2 T TRAVATAN Z 0.004 % EYE DROPS... 7 U ULORIC 40 MG TABLET... 9 ULORIC 80 MG TABLET... 9 Z ZETONNA 37 MCG/ACTUATION NASAL HFA INHALER... 6 ZIOPTAN (PF) 0.0015 % EYE DROPS IN A DROPPERETTE... 7 ZOMIG 2.5 MG NASAL SPRAY... 5 ZOMIG 5 MG NASAL SPRAY... 5 10